Discussion of "Analysis of variance--why it is more important than ever"
  by A. Gelman by Zaslavsky, Alan M.
ar
X
iv
:m
at
h/
05
08
52
9v
1 
 [m
ath
.ST
]  
26
 A
ug
 20
05
The Annals of Statistics
2005, Vol. 33, No. 1, 43–47
DOI: 10.1214/009053604000001048
c© Institute of Mathematical Statistics, 2005
DISCUSSION OF “ANALYSIS OF VARIANCE—WHY IT IS MORE
IMPORTANT THAN EVER” BY A. GELMAN
By Alan M. Zaslavsky
Harvard University
Andrew Gelman’s contribution shifts the focus of “Analysis of Variance”
(ANOVA) from the limited sense in which it has been commonly used in
classical statistics, as a method of testing, to the broader framework of esti-
mation and inference. The term more commonly used in this sense, “variance
components modeling,” also captures the same spirit. The essential idea is
that of constructing distributions by using ideas of exchangeability; each
variance component corresponds to a collection of exchangeable effects. This
extremely powerful approach to linking the scientific structure of a dataset
with a model has been and will continue to be widely applicable.
The transition from ANOVA to variance components modeling shifts at-
tention from decomposition of the variance of the sample as in classical
ANOVA to decomposition of the variance of the population. This shift in
focus is appropriate to a world in which scientific questions become increas-
ingly complex and are less frequently answerable through simple designed
experiments.
As Gelman notes, in a Bayesian framework the estimation of variance
components is relatively automatic; attention can be focused on defining
sensible models rather than on constructing designs that can be analyzed
easily.
Finally, Gelman’s discussion of the manifold definitions of “fixed and ran-
dom effects” is itself worth the price of admission.
1. Testing and prior distributions. Gelman reserves the issue of model
specification, specifically testing of variance components, to a short section
(Section 8.2) toward the end of the article (alluding to it only briefly in
Section 3.4). Testing variance components is inherently different from testing
a regression coefficient because the null hypothesis σ2 = 0 is on the boundary
of the parameter space. The difficulties this causes for hypothesis testing in
the likelihood framework are well known.
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In a Bayesian setting, we might distinguish two purposes of hypothesis
testing: determining whether a scientifically interesting conclusion can be
drawn with adequate certainty to be worth reporting, and selecting models
(omitting unneeded model effects). For “scientific” testing of a regression
coefficient we might select a locally uniform prior and then see whether we
can at least be adequately confident of its sign, that is, is either P (β >
0) or P (β < 0) a posteriori close enough to 1? For a variance component,
the boundary problem prevents defining a locally uniform prior or applying
this “two-sided” approach. (Scale-invariant improper priors typically yield
degenerate posteriors in variance components models.)
A “model-mixing” approach combines a point mass at the null with a
proper distribution over the remainder of the distribution. I find this unsat-
isfactory as a default solution, especially in the context of independent priors
on the magnitudes of variance components, because it requires informative
prior beliefs about both the probability of the null hypotheses σ2
m
= 0 (and
the various combinations of nulls) and the scale of the variance component
if nonzero.
We might avoid the scaling problem by defining prior distributions for
relative variances σ2
m
/
∑
m
′ σ2
m
′ rather than absolute variances σ2
m
. It is more
natural to combine this prior with point masses for submodels because the
prior probabilities for the submodels are relative to the distribution of a
variable that is always scaled on (0,1); the notion of a “small enough to
be scientifically uninteresting” component is also more readily interpretable
on a relative scale. Such a prior could also accommodate prior information
about relative magnitudes of variance components as suggested by Gelman.
Note that Gelman’s suggestion of independent uniform priors on each com-
ponent implies a uniform prior on these relative variance components, that
is, a Dirichlet(δ, δ, . . . , δ) prior with δ = 1, conditional on the sum of the vari-
ance components (the marginal variance of the data in an additive model).
A prior belief that the variance components should be nearly equal suggests
a similar prior with δ≫ 1, and if we believe that a few components should
predominate, then we might assume 0< δ < 1. At least in additive models,
this prior specification allows us to separate specification of the prior for
the marginal variance of the data from that for the ratios of components;
such a separation is more difficult with independent priors for the different
components.
I find posterior predictive tests [Rubin (1984) and Meng (1994)] a more
satisfactory way to test variance components than model mixing: we fix a
component at zero, and then by simulating data from its predictive distri-
bution determine whether the observed value of a statistic related to that
component in some monotone way is consistent with the predictions of the
constrained model. Indeed, the sums-of-squares statistics of the classical
ANOVA table are suitable for such a test. The boundary problem is not an
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issue with this approach since the reference distribution is determined by
simulation rather than by asymptotics, and indeed no prior distribution is
required for the variance component being tested. I would conjecture that
for balanced data, the sums-of-squares statistics are optimal for posterior
predictive testing of the null hypothesis on the corresponding variance com-
ponents. An interesting research direction would be to prove this conjecture
or find a superior statistic for the balanced case, and then to identify better
statistics for posterior predictive testing with unbalanced data.
We might also be interested in testing as a means of selecting a model with
fewer nuisance parameters, specifically by reducing the number of variance
components. For this objective a conservative approach would incline toward
retaining as many components as possible, but with a prior distribution that
allows their estimates to stay close to zero if there is little or no evidence for
nonzero values, possibly by using a small value of δ in a “relative” Dirichlet
prior. Sensitivity of inferences of interest to the choice of prior might indicate
that the data cannot unequivocally answer the questions of interest.
2. Variance components as a focus of scientific research. Much of the
applied multilevel modeling literature treats variance components as nui-
sance parameters, putting the primary emphasis on estimation and testing
of regression coefficients (representing scientifically interesting systematic re-
lationships) or of functions of random effects (small area estimation in survey
sampling and official statistics, profiling in health care, “league tables” for
schools). An important exception is genetics, in which variance components
are the basis for calculations of heritability. In my own applied research,
I have found that variance components are also an inherently interesting
object of inference. Two examples follow.
An analysis of predictors of administration of clinically appropriate chemother-
apy for colorectal cancer estimated a residual variance component for hospi-
tal effects, after controlling for measured hospital and patient characteristics
[Ayanian et al. (2003)]. To explain the importance of this variation to clinical
readers, we noted that the difference between a moderately above-average
and a moderately below-average hospital (1 SD above or below average)
was about as large as the effect of the most important patient characteristic
identified in the model. The large magnitude of this residual variation sug-
gests that measurement of additional hospital characteristics might yield a
scientific payoff. Furthermore, quality improvement activities might be di-
rected to bringing lower-performing hospitals closer to the practices of their
better-performing peers, consistent with arguments that substantial unex-
plained variation in rates of use of a medical procedure is in itself evidence
of poor quality [Wennberg and Gittelsohn (1982)].
Samples of members of Medicare managed care health plans (private or-
ganizations that contract with the U.S. government to provide health care
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to elderly or disabled individuals) have been administered a survey annually
for the last eight years to assess various aspects of the services they receive
[Zaslavsky, Zaborski and Cleary (2004)]. The effects of measured charac-
teristics of individual members or plans are fairly small, and the effects
of an individual’s characteristics are of little interest because the primary
objective of the survey is to evaluate health care systems, not the predic-
tors of an individual’s reported experiences. These data were modeled with
variance components for three levels of nested geographical units (region,
state, Metropolitan Statistical Area or MSA) and for the organizational unit
(the health plan). For ratings of “the plan” (primarily reflecting the qual-
ity of customer service interactions), the majority of variance (excluding
the large bottom-level individual component) was explained by the organi-
zational unit. However, the explainable variance for ratings of doctors was
mainly attributable to geographical variation, with a smaller component at-
tributable to the health plan. We interpreted this finding as reflecting the
fact that the health plans have more control over customer services provided
directly by the plan than over health care. The latter is largely provided by
doctors and hospitals that are organizationally independent of the plans and
might contract with multiple plans; other studies have shown substantial ge-
ographical variation in their practice patterns. This finding has implications
for quality improvement, suggesting that interventions to improve quality
of care might have to be directed to health care providers in an area rather
than trying to identify and improve lower-performing health plans. Similar
patterns were identified for other quality dimensions measured in the survey.
A further analysis estimated variance components for the geographical units,
the plan organization, time (year of survey administration) and interactions
of these effects. The time effects were interesting in evaluating the extent
to which relative changes in quality might be detected between consecutive
years, while the plan by MSA interaction was useful for deciding whether to
generate separate estimates by geographical area within large plans serving
extensive areas. Estimation of these complex models was made possible by
the unusual size of the survey datasets (over 700,000 respondents).
These examples illustrate that despite their relative unfamiliarity in many
fields, variance components can be interpreted to nonstatisticians in a sci-
entifically meaningful way.
3. Miscellaneous comments.
Finite population variance components. Gelman correctly notes that in-
ference can be made for both finite-population and superpopulation vari-
ances, and that the distinction between these two targets of inference cor-
responds to the distinction between fixed and random effects. In my experi-
ence, estimation of a finite-population variance is relatively rarely of interest.
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When we are really concerned about a specific set of units (such as alter-
native treatments in an experiment), we are likely to estimate rankings of
and differences among those units as a basis for future action. On the other
hand, when estimation of the variance component is intended as part of an
inference about a more general law (as is common in econometric analyses
of U.S. state data), we are likely to think of the finite population as part
of a larger hypothetical population even if (as the 50 states) they in fact
constitute the entire population.
Method of moments. Gelman draws out the connection between classical
ANOVA and method-of-moments variance components estimators. Because
these estimators are essentially linear combinations of variance statistics
that can be directly calculated from the data, they have substantial heuristic
value, since maximum-likelihood or Bayesian estimation in complex prob-
lems can be too much of a “black box” to yield adequate direct insight into
the connection between the data and the parameter estimates. On the other
hand, the simple decomposition of Gelman’s equation (1) only applies when
there are unbiased estimators with independent errors, which is not likely
to be the case for complex models with unbalanced datasets.
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